| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8486760 | Vaccine | 2012 | 7 Pages |
Abstract
⺠The cost-effectiveness of novel rotavirus vaccines is uncertain in the Canadian context. ⺠An economic analysis was performed for rotavirus vaccine preparations in Canada. ⺠A monovalent vaccine (Rotarix) was highly cost-effective. ⺠A pentavalent vaccine (RotaTeq) was less effective and cost more, and was “dominated”. ⺠Findings remained robust in the face of wide-ranging sensitivity and uncertainty analyses.
Keywords
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
David N. Fisman, Christina H. Chan, Elizabeth Lowcock, Monika Naus, Victoria Lee,